Perimenopause and Your Heart: Why Cardiovascular Risk Changes After 45
Declining oestrogen during perimenopause raises LDL cholesterol and blood pressure. Learn why heart risk shifts after 45 and which checks to request early.
Most women spend decades hearing that heart disease is a man's problem. Then, somewhere around 45, their bloodwork tells a different story. The hormonal shift of perimenopause quietly rewires cardiovascular risk, and the earlier you understand why, the more you can do about it.
How Oestrogen Protects the Heart, Until It Doesn't
Before perimenopause, oestrogen acts as a quiet guardian of cardiovascular function. It promotes the production of nitric oxide in blood vessel walls, which keeps arteries flexible and dilated. It supports favourable cholesterol ratios by helping the liver clear LDL (low-density lipoprotein) from the bloodstream and maintain HDL (high-density lipoprotein) levels.
Oestrogen also has anti-inflammatory effects on the vascular endothelium, the thin layer of cells lining every artery. When oestrogen levels are stable, this lining repairs itself efficiently and resists the plaque-building process known as atherosclerosis.
During perimenopause, oestrogen does not simply switch off. It fluctuates wildly, sometimes spiking higher than premenopausal levels before crashing again. These erratic swings can last anywhere from two to ten years before menstruation stops entirely. It is in this transition, not after the final period, that measurable cardiovascular changes begin.
Why LDL Cholesterol Climbs During the Transition
A menopause cholesterol increase catches many women off guard. Blood tests that were unremarkable at 40 may show a 10 to 15 percent rise in LDL by the late 40s, even without changes in diet or exercise.
The mechanism is straightforward. Oestrogen upregulates LDL receptors on liver cells. These receptors pull LDL particles out of the blood for processing. As oestrogen declines, fewer receptors are expressed, and LDL lingers in circulation longer. Over time, those particles are more likely to infiltrate artery walls and trigger plaque formation.
Total cholesterol and triglycerides tend to rise as well. Meanwhile, HDL, often called "good" cholesterol, may drop or lose some of its protective function. The net effect is a lipid profile that shifts toward higher cardiovascular risk within a relatively short window.
Blood Pressure: The Silent Shift
Perimenopause heart health discussions often focus on cholesterol, but blood pressure deserves equal attention. Oestrogen helps blood vessels relax through its influence on nitric oxide and on the renin-angiotensin-aldosterone system, the hormonal cascade that regulates blood volume and vessel constriction.
As oestrogen wanes, arterial stiffness increases. The vessels become less responsive to the normal signals that keep pressure in check. Women who have had textbook-perfect readings for decades may notice a gradual creep into the elevated or stage-one hypertension range.
This shift is easy to miss. Blood pressure is often checked only at routine appointments, and "white coat" anxiety can muddy the numbers. Home monitoring over several weeks gives a far more accurate picture.
Insulin Resistance Enters the Picture
Hormonal changes during perimenopause also affect how the body handles glucose. Declining oestrogen and progesterone alter insulin sensitivity, making cells less efficient at absorbing blood sugar. The result can be higher fasting glucose, increased insulin output, and a greater tendency to store visceral fat around the abdomen.
Visceral fat is metabolically active. It releases inflammatory cytokines that further damage blood vessels and worsen insulin resistance, creating a feedback loop. This is one reason why cardiovascular risk accelerates in women after 45, even those who maintain a healthy weight by standard BMI measures.
Waist circumference is often a more useful marker than overall weight during this transition. A measurement above 80 cm is associated with increased metabolic and cardiovascular risk in women.
What to Check Early, and How Often
Waiting until after menopause to assess heart risk means missing the window where early intervention is most effective. The following checks are worth discussing with your doctor from your mid-40s onward:
- Fasting lipid panel - Total cholesterol, LDL, HDL, and triglycerides. Consider annual testing during the perimenopausal transition rather than every five years.
- Fasting glucose and HbA1c - These markers reveal how well your body is managing blood sugar over time.
- Blood pressure - Ideally tracked at home over a two-week period for a baseline, then periodically reassessed.
- Waist circumference - A simple measurement that adds context to standard weight checks.
- High-sensitivity C-reactive protein (hs-CRP) - A marker of systemic inflammation that can help stratify risk when lipid numbers are borderline.
- Thyroid function - Thyroid disorders become more common during perimenopause and can independently raise cholesterol and blood pressure.
Establishing a baseline before numbers climb gives you and your clinician a reference point. Trends matter as much as absolute values.
Lifestyle Levers That Actually Move the Needle
Medication is sometimes necessary, but lifestyle measures remain the foundation of perimenopause heart health. The following strategies have well-established effects on the specific risks that rise during this transition:
- Resistance training - Building and maintaining muscle mass improves insulin sensitivity and supports healthy blood pressure. Aim for at least two sessions per week.
- Aerobic exercise - Sustained moderate-intensity activity, such as brisk walking, cycling, or swimming, directly benefits endothelial function and lipid profiles. 150 minutes per week is the standard recommendation.
- Dietary fibre - Soluble fibre from oats, legumes, and vegetables binds bile acids in the gut, forcing the liver to use circulating cholesterol to make more. This mechanism genuinely lowers LDL.
- Limiting ultra-processed foods - These foods tend to be high in refined carbohydrates, sodium, and industrial fats, all of which worsen the metabolic changes of perimenopause.
- Sleep quality - Poor sleep raises cortisol, worsens insulin resistance, and elevates blood pressure. Night sweats and hormonal insomnia make this a genuine challenge during perimenopause, and it is worth addressing directly rather than dismissing as inevitable.
- Stress management - Chronic stress activates the sympathetic nervous system and raises blood pressure. Structured approaches, whether meditation, therapy, or simply protecting recovery time, have measurable cardiovascular benefits.
The Role of Hormone Replacement Therapy
Hormone replacement therapy (HRT) can address many perimenopausal symptoms, and its cardiovascular effects depend heavily on timing. Evidence suggests that starting HRT within ten years of menopause onset or before age 60 may offer cardiovascular benefit, partly by restoring oestrogen's effects on lipids and arterial function.
Starting HRT well after menopause, particularly in women who already have established atherosclerosis, carries different risks. This is why the decision is highly individual and should involve a thorough assessment of personal and family history, current risk factors, and symptom burden.
HRT is not a substitute for the lifestyle and monitoring strategies described above, but for the right candidate, it can be a meaningful part of a broader cardiovascular plan.
Why Telehealth Fits This Conversation
Many of the assessments relevant to perimenopause heart health, reviewing blood results, discussing symptom patterns, adjusting monitoring plans, do not require a physical examination every time. Telehealth consultations can fill the gaps between in-person visits, making it easier to act on trends rather than waiting for annual appointments.
This is especially valuable during a transition that unfolds over years and involves multiple overlapping changes. Having access to a clinician who can interpret your results in context and help you decide what to escalate saves time and reduces the chance of important shifts being overlooked.
Telehealth complements, rather than replaces, hands-on care. Physical examinations, imaging, and certain diagnostic procedures still require in-person visits, but a significant portion of ongoing cardiovascular risk management can be supported remotely.
This article is for informational purposes only and does not constitute personalised medical advice. If you have concerns about your cardiovascular health during perimenopause, consult a licensed physician who can assess your individual risk factors and recommend appropriate screening or treatment.
About AETHERA Health
AETHERA Health is an EU-licensed telehealth platform founded and clinically led by Hilaryano Ferreira, cardiologist and co-author of peer-reviewed research on AI in remote cardiac care. Every diagnosis, prescription and clinical decision on the platform is made by a licensed physician.
Related articles
Ready to take control of your health?
Get matched with an EU-licensed physician in minutes.
Start Free Assessment